FDA official logo
GSRS logoPFDA official logo

CILTACABTAGENE AUTOLEUCEL

UNII:0L1F17908Q
Formula:
Preferred Substance Name:CILTACABTAGENE AUTOLEUCEL

  • AUTOLOGOUS BI-EPITOPE BCMA-TARGETED CAR T-CELLS JNJ-68284528
  • AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEAR CELL (PBMC)-DERIVED T LYMPHOCYTES TRANSDUCED EX VIVO WITH A NON-REPLICATING, SELF-INACTIVATING (SIN) LENTIVIRAL VECTOR ENCODINGA CHIMERIC ANTIGEN RECEPTOR (CAR) TARGETING TWO EPITOPES OF THE HUMAN B CELL MATURATION ANTIGEN (BCMA) UNDER THE CONTROL OF A HUMAN ELONGATION FACTOR 1 ALPHA (EF1.ALPHA.) PROMOTER THE CODING SEQUENCE COMPRISES A HUMAN CD8 ALPHA SIGNAL PEPTIDE (CD8.ALPHA. SP), A BCMA TARGETING DOMAIN CONSISTING OF TWO VARIABLE HEAVY CHAIN-ONLY ANTIBODIES (VHH1 AND VHH2) TARGETING TWO DISTINCT BCMA EPITOPES, A HUMAN CD8 ALPHA HINGE AND TRANSMEMBRANE DOMAIN (CD8.ALPHA. HINGE + TM), A HUMAN CD137 CYTOPLASMIC DOMAIN (4-1BB) AND A HUMAN CD3 ZETA CYTOPLASMIC DOMAIN (CD3.ZETA.). THE VECTOR GENOME CONTAINS A CHIMERIC ROUS SARCOMA VIRUS (RSV)/TRUNCATED 5'LTR AND A SELF-INACTIVATING 3'LTR-SIN (.DELTA.-U3)
  • CILTACABTAGENE AUTOLEUCEL [INN]
  • CILTACABTAGENE AUTOLEUCEL [USAN]
  • CILTACABTAGENE AUTOLEUCEL [WHO-DD]
  • JNJ-68284528
  • LCAR-B38M-TRANSDUCED CAR-T CELLS JNJ-68284528



UNII - 0L1F17908Q | UNII Search Service